<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03325426</url>
  </required_header>
  <id_info>
    <org_study_id>16-18605</org_study_id>
    <nct_id>NCT03325426</nct_id>
  </id_info>
  <brief_title>Activity Trackers for Improving BP</brief_title>
  <official_title>ACtivity Trackers to ImproVe Blood Pressure: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine if use of physical activity trackers coupled with provider
      feedback will increase awareness of young adults of their physical fitness and improve blood
      pressure levels. The goal of this pilot study is feasibility, with a secondary goal of
      examining potential effect sizes for planning purposes for a larger randomized controlled
      trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Increasing physical activity levels may improve cardiovascular health and BP levels in young
      individuals, especially if such strategies promote healthy lifestyles. Physical activity is
      currently recommended for adults CV health, but physical activity levels are known to be low
      in populations with diabetes or chronic kidney disease. One prior study of the use of
      pedometers (not associated with wireless technology or provider feedback) in children with
      CKD did not significantly improve physical activity levels. Supervised walking appeared to
      provide some benefit in individuals with type II diabetes, but overall compliance was poor.
      Interview of adolescents and young adults with chronic illnesses has shown preference for the
      use of electronic devices and online tools for disease management.Thus, use of sophisticated
      electronic devices such as FitBits© (wireless pedometers worn on the wrist that sync with
      cell phones) may improve disease control by engaging young patients in self-monitoring of
      their own health and lifestyle behaviors. This pilot study aims to determine if use of
      FitBits© coupled with provider feedback will increase awareness of young adults of their
      physical fitness and improve blood pressure levels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in mean office systolic and diastolic BP</measure>
    <time_frame>Months 3-9</time_frame>
    <description>Compared across usual care versus intervention arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Enrollment numbers</measure>
    <time_frame>Months 0-12</time_frame>
    <description>Feasibility of enrollment and study retention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight change</measure>
    <time_frame>Months 3-9</time_frame>
    <description>Compared across usual care versus intervention arms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Hypertension</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Physical Activity</condition>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity tracker</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FitBit</intervention_name>
    <description>Daily use of physical activity tracker coupled with weekly provider telemonitoring and feedback for 3 months</description>
    <arm_group_label>Physical activity tracker</arm_group_label>
    <other_name>physical activity tracker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages 12-30 receiving anti-hypertensive therapy at the time of recruitment.

          -  diabetes, non-dialysis requiring chronic kidney disease, kidney transplant, or other
             etiologies of hypertension

          -  have phones compatible for wireless device (FitBits©) data transmission

        Exclusion Criteria:

          -  history of decompensated congestive heart failure

          -  pregnant

          -  cognitive impairment

          -  unable to perform physical activity

          -  BP &gt;180/110 mm Hg

          -  prisoners

          -  contraindication to use or wear of home activity tracker (such as allergy to activity
             tracker band)

          -  presence of any co-morbidity that would preclude physical activity

          -  actively using physical activity tracking devices prior to the study will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elaine Ku</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elaine Ku, MD</last_name>
    <phone>415-353-2507</phone>
    <email>Elaine.Ku@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Se Ri Bae, BA</last_name>
    <phone>4159173233</phone>
    <email>seri.bae@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Se Ri Bae, BA</last_name>
      <phone>415-917-3233</phone>
      <email>seri.bae@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Divya Seth</last_name>
      <phone>4155010385</phone>
      <email>divya.seth@ucsf.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cohen DL, Huan Y, Townsend RR. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2014 May;63(5):835-42. doi: 10.1053/j.ajkd.2013.12.015. Epub 2014 Feb 12. Review.</citation>
    <PMID>24529535</PMID>
  </reference>
  <reference>
    <citation>Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, Rizo CA, Feig DS, Hamill M, Trudel M, Cafazzo JA. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007 Sep;20(9):942-8.</citation>
    <PMID>17765133</PMID>
  </reference>
  <reference>
    <citation>Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011 Jan;57(1):29-38. doi: 10.1161/HYPERTENSIONAHA.110.160911. Epub 2010 Nov 29. Review.</citation>
    <PMID>21115879</PMID>
  </reference>
  <reference>
    <citation>Uhlig K, Balk EM, Patel K, Ip S, Kitsios GD, Obadan NO, Haynes SM, Stefan M, Rao M, Kong Win Chang L, Gaylor J, Iovin RC. Self-Measured Blood Pressure Monitoring: Comparative Effectiveness [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jan. Available from http://www.ncbi.nlm.nih.gov/books/NBK84604/</citation>
    <PMID>22439158</PMID>
  </reference>
  <reference>
    <citation>Akber A, Portale AA, Johansen KL. Pedometer-assessed physical activity in children and young adults with CKD. Clin J Am Soc Nephrol. 2012 May;7(5):720-6. doi: 10.2215/CJN.06330611. Epub 2012 Mar 15.</citation>
    <PMID>22422539</PMID>
  </reference>
  <reference>
    <citation>Mohammed J, Deda L, Clarson CL, Stein RI, Cuerden MS, Mahmud FH. Assessment of habitual physical activity in adolescents with type 1 diabetes. Can J Diabetes. 2014 Aug;38(4):250-5. doi: 10.1016/j.jcjd.2014.05.010.</citation>
    <PMID>25092645</PMID>
  </reference>
  <reference>
    <citation>Akber A, Portale AA, Johansen KL. Use of pedometers to increase physical activity among children and adolescents with chronic kidney disease. Pediatr Nephrol. 2014 Aug;29(8):1395-402. doi: 10.1007/s00467-014-2787-6. Epub 2014 Mar 20.</citation>
    <PMID>24648129</PMID>
  </reference>
  <reference>
    <citation>Negri C, Bacchi E, Morgante S, Soave D, Marques A, Menghini E, Muggeo M, Bonora E, Moghetti P. Supervised walking groups to increase physical activity in type 2 diabetic patients. Diabetes Care. 2010 Nov;33(11):2333-5. doi: 10.2337/dc10-0877.</citation>
    <PMID>20980426</PMID>
  </reference>
  <reference>
    <citation>Applebaum MA, Lawson EF, von Scheven E. Perception of transition readiness and preferences for use of technology in transition programs: teens' ideas for the future. Int J Adolesc Med Health. 2013;25(2):119-25. doi: 10.1515/ijamh-2013-0019.</citation>
    <PMID>23740658</PMID>
  </reference>
  <reference>
    <citation>Ting TV, Kudalkar D, Nelson S, Cortina S, Pendl J, Budhani S, Neville J, Taylor J, Huggins J, Drotar D, Brunner HI. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol. 2012 Jan;39(1):174-9. doi: 10.3899/jrheum.110771. Epub 2011 Nov 15.</citation>
    <PMID>22089460</PMID>
  </reference>
  <reference>
    <citation>Takacs J, Pollock CL, Guenther JR, Bahar M, Napier C, Hunt MA. Validation of the Fitbit One activity monitor device during treadmill walking. J Sci Med Sport. 2014 Sep;17(5):496-500. doi: 10.1016/j.jsams.2013.10.241. Epub 2013 Oct 31.</citation>
    <PMID>24268570</PMID>
  </reference>
  <reference>
    <citation>James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809.</citation>
    <PMID>24352797</PMID>
  </reference>
  <reference>
    <citation>Tudor-Locke C, Pangrazi RP, Corbin CB, Rutherford WJ, Vincent SD, Raustorp A, Tomson LM, Cuddihy TF. BMI-referenced standards for recommended pedometer-determined steps/day in children. Prev Med. 2004 Jun;38(6):857-64.</citation>
    <PMID>15193909</PMID>
  </reference>
  <reference>
    <citation>Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005 Feb 8;111(5):697-716.</citation>
    <PMID>15699287</PMID>
  </reference>
  <reference>
    <citation>Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, Zachariah JP, Urbina EM; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014 May;63(5):1116-35. doi: 10.1161/HYP.0000000000000007. Epub 2014 Mar 3.</citation>
    <PMID>24591341</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Elaine Ku, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

